The 13th EDCTP Forum will bring together researchers, policymakers, and funders to reinforce scientific collaboration, forge new partnerships and advance responses to shared health challenges

Through collaboration with European health bodies, Global Health EDCTP3 aims to strengthen tuberculosis prevention and treatment, especially involving children and people with weakened immune systems

In 2026, the Global Health EDCTP3 Joint Undertaking will fund up to €147 million in research and innovation projects tackling tuberculosis, lower respiratory tract infections, HIV and climate-change-driven infectious diseases, among other topics. The calls for proposals opened for submission on 14 January 2026. 

Launched in 2003 in response to the Millennium Development Goals and more recently the Sustainable Development Goals, the European & Developing Countries Clinical Trials Partnership (EDCTP) has supported groundbreaking innovations like paediatric HIV and tuberculosis medicines, malaria vaccines and treatments, as well as treatments for neglected tropical diseases. These advances are saving and improving lives and strengthening global health security.

Co-authored by: 
Martin Fitchet, Executive Director of Medicines for Malaria Venture (MMV), 
Luis Pizarro, Executive Director of the Drugs for Neglected Diseases Initiative (DNDi), and 
Marina Gold, Executive Director of Mundo Sano.